ArticleInternational journal of cancer2020

Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo.

Kristin Gurtner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.